Prevention of irinotecan plus 5-fluorouracil/leucovorin-induced diarrhoea by oral administration of neomycin plus bacitracin in first-line treatment of advanced colorectal cancer

Ann Oncol. 2003 May;14(5):805-6. doi: 10.1093/annonc/mdg193.
No abstract available

Publication types

  • Letter

MeSH terms

  • Administration, Oral
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Bacitracin / administration & dosage*
  • Bacitracin / adverse effects
  • Camptothecin / administration & dosage
  • Camptothecin / adverse effects*
  • Camptothecin / analogs & derivatives*
  • Colorectal Neoplasms / drug therapy*
  • Diarrhea / chemically induced
  • Diarrhea / prevention & control*
  • Fluorouracil / administration & dosage
  • Fluorouracil / adverse effects
  • Humans
  • Irinotecan
  • Leucovorin / administration & dosage
  • Leucovorin / adverse effects*
  • Neomycin / administration & dosage*
  • Neomycin / adverse effects

Substances

  • Bacitracin
  • Irinotecan
  • Neomycin
  • Leucovorin
  • Fluorouracil
  • Camptothecin